Financial Health Assessment: EVOGRO LTD

Financial Health Score: B-

Explanation: EVOGRO shows the classic vital signs of a venture-backed growth company—strong liquidity and increasing investment, but significant accumulated losses that indicate the business has not yet achieved sustainable profitability. The recent capital injection has improved the patient's condition considerably, but the underlying business model must demonstrate it can generate consistent revenue to support its development-heavy cost structure.

Key Vital Signs

Diagnosis

What the Financial Data Reveals About Business Health

The Patient's Condition: A Well-Funded Scale-Up in Pre-Profitability Phase

EVOGRO is a company that designs and manufactures smart kitchen growing devices (for salad leaves, microgreens, and herbs). The financial data tells the story of a business that has been investing heavily in product development since incorporation in 2011, and is now scaling operations.

Positive Indicators (Healthy Vital Signs)

1. Exceptional Cash Recovery The cash position has surged from £189,104 to £745,046—nearly a fourfold increase. This is the financial equivalent of a patient receiving a transfusion; the company has clearly secured significant new funding. The share premium account increased by £562,809 (from £2,626,198 to £3,189,007), confirming new equity investment.

2. Strong Liquidity With a current ratio of 4.73x, EVOGRO can cover its short-term obligations nearly five times over. This is a very comfortable position—think of it as having excellent cardiovascular fitness. The company is not at risk of short-term cash flow problems.

3. Continued R&D Investment Capitalised development costs increased by £568,429 during the year, bringing the total investment to £2,255,607. This demonstrates ongoing commitment to product innovation and suggests the company believes in future commercial returns from its technology.

4. Growing Operations Employee numbers increased from 13 to 15, and debtors grew from £134,704 to £234,013—a 74% increase that likely indicates growing revenue activity.

Concerning Symptoms (Areas Requiring Attention)

1. Deep Accumulated Losses The retained earnings deficit of £2,144,269 represents the cumulative losses over the company's lifetime. While common for venture-backed businesses, this is a significant wound that needs healing. The losses increased by £376,637 during the year, meaning the company is still burning cash operationally.

2. Sharp Increase in Long-Term Liabilities Long-term liabilities jumped from £204,044 to £886,482—an increase of £682,438. This could represent: - A new loan facility (potentially alongside the equity raise) - Convertible debt instruments - Related party loans

Without visibility into the terms, this represents a significant unknown. If this is debt requiring repayment, it could constrain future cash flow.

3. Heavy Reliance on Intangible Assets Capitalised development costs of £1,267,459 (net of amortisation) represent approximately 55% of total assets. This is the financial equivalent of having most of your organs functioning but relying heavily on one—if product commercialisation fails, these assets may need to be impaired, which would dramatically reduce net assets.

4. Stock Levels Declining Stock decreased from £103,984 to £50,991—a 51% reduction. This could indicate: - Better inventory management (positive) - Supply chain issues (concerning) - Slower production activity (needs investigation)

Prognosis

Future Financial Outlook

Short-term (12 months): POSITIVE The company has strong cash reserves and excellent liquidity. There are no immediate solvency concerns, and the business appears well-capitalised to continue operations and development.

Medium-term (1-3 years): UNCERTAIN BUT HOPEFUL The critical question is whether EVOGRO can transition from investment phase to profitable trading. The increasing debtors suggest revenue growth, but without seeing the profit & loss account (exempt under small company rules), we cannot assess the trajectory toward profitability.

Key Risk: The company must achieve sufficient revenue to cover operating costs before the current cash reserves are depleted. At the current loss rate (approximately £376,637 for the year), the £745,046 cash reserve provides roughly 2 years of runway—but only if losses don't increase as the business scales.

Long-term: Depends entirely on product-market fit and the ability to generate sustainable margins on what appears to be a premium consumer product.

Recommendations

Specific Actions to Improve Financial Wellness

1. Critical: Path to Profitability Planning Develop a detailed month-by-month cash flow forecast mapping the route to breakeven. The company should establish clear milestones for revenue targets and monitor progress monthly. Think of this as creating a treatment plan with measurable health targets.

2. Important: Clarify Long-Term Liability Structure Understand and document the terms of the £886,482 in long-term liabilities: - What are the repayment schedules? - Are there conversion features (e.g., convertible loan notes)? - What covenants or restrictions apply?

3. Important: Development Cost Impairment Review With £2.26M invested in development costs, conduct a rigorous annual impairment review. For each capitalised project, assess: - Is the product still technically viable? - Is there a clear market demand? - Are there adequate resources to complete development? - Can the expenditure be reliably measured?

If any projects are no longer expected to generate future economic benefits, they should be written off promptly—delaying this is like ignoring symptoms that won't resolve on their own.

4. Recommended: Revenue Diversification Given the niche product offering (kitchen growing devices), consider whether the technology can be licensed or applied to other markets (commercial agriculture, restaurant sector, etc.) to reduce dependency on a single product category.

5. Recommended: Working Capital Optimisation While liquidity is currently strong, continue to manage: - Stock levels (ensure efficient production planning) - Debtor days (monitor the growing debtor balance) - Supplier payment terms

6. Monitor: Cash Burn Rate Track monthly cash consumption against the business plan. The current cash position is healthy, but the company should maintain a minimum of 6 months' operating expenses as a buffer. At current rates, this would be approximately £188,000—well within current reserves.

Summary Dashboard